Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:GUTSNASDAQ:ICADNASDAQ:NMTCNASDAQ:ZJYL On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeGUTSFractyl Health$2.06-5.1%$1.61$0.87▼$5.74$100.89M1.85327,579 shs290,851 shsICADiCAD$3.68-2.1%$3.37$1.18▼$4.02$101.09M1.38422,133 shs154,926 shsNMTCNeuroOne Medical Technologies$0.56-2.1%$0.59$0.40▼$1.39$28.00M0.63185,211 shs50,566 shsZJYLJin Medical International$0.68-1.8%$0.79$0.56▼$4.38$106.86M10.67289,289 shs39,633 shs13 Stocks Institutional Investors Won't Stop BuyingWhich stocks are hedge funds and endowments buying in today's market? Enter your email address and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying now.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceGUTSFractyl Health0.00%+3.52%+24.85%+60.94%-66.23%ICADiCAD0.00%-5.64%-6.12%+60.70%+138.96%NMTCNeuroOne Medical Technologies0.00%-3.39%-14.33%-47.96%-37.84%ZJYLJin Medical International0.00%-11.32%-17.26%-19.85%-74.14%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationGUTSFractyl Health2.2996 of 5 stars3.52.00.00.03.50.00.0ICADiCAD0.9762 of 5 stars0.05.00.00.02.80.80.0NMTCNeuroOne Medical Technologies2.3364 of 5 stars3.53.00.00.02.71.70.0ZJYLJin Medical InternationalN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceGUTSFractyl Health 3.00Buy$11.00433.98% UpsideICADiCAD 2.00HoldN/AN/ANMTCNeuroOne Medical Technologies 3.00Buy$1.45158.01% UpsideZJYLJin Medical International 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NMTC, GUTS, ICAD, and ZJYL Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails5/5/2025NMTCNeuroOne Medical TechnologiesLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$1.454/17/2025ICADiCADLaidlawSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Hold4/16/2025ICADiCADBTIG ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeBuy ➝ Neutral4/16/2025ICADiCADCraig HallumSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeStrong-Buy ➝ Hold4/15/2025GUTSFractyl HealthCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$12.00(Data available from 6/15/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookGUTSFractyl Health$60K1,681.54N/AN/AN/A∞ICADiCAD$19.53M5.18N/AN/A$1.27 per share2.90NMTCNeuroOne Medical Technologies$5.76M4.86N/AN/A$0.10 per share5.62ZJYLJin Medical International$23.50M4.55$0.02 per share31.44$0.18 per share3.79Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateGUTSFractyl Health-$77.09M-$1.85N/AN/AN/A-64,849.48%N/A-57.21%8/13/2025 (Estimated)ICADiCAD-$4.85M-$0.19N/A∞N/A-17.81%-15.65%-12.52%8/14/2025 (Estimated)NMTCNeuroOne Medical Technologies-$12.32M-$0.22N/A∞N/A-82.17%-270.70%-129.70%8/13/2025 (Estimated)ZJYLJin Medical International$3.68MN/A0.00∞N/AN/AN/AN/AN/ALatest NMTC, GUTS, ICAD, and ZJYL EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/13/2025Q1 2025GUTSFractyl Health-$0.49-$0.49N/A-$0.49N/AN/A5/13/2025Q1 2025ICADiCAD-$0.0625-$0.02+$0.0425-$0.03$4.54 million$4.87 million5/13/2025Q2 2025NMTCNeuroOne Medical Technologies-$0.09-$0.07+$0.02-$0.07$1.27 billion$1.39 billion3/19/2025Q4 2024ICADiCAD-$0.0525-$0.03+$0.0225-$0.03$4.72 million$5.41 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthGUTSFractyl HealthN/AN/AN/AN/AN/AICADiCADN/AN/AN/AN/AN/ANMTCNeuroOne Medical TechnologiesN/AN/AN/AN/AN/AZJYLJin Medical InternationalN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioGUTSFractyl Health0.605.585.57ICADiCADN/A4.023.91NMTCNeuroOne Medical TechnologiesN/A3.642.41ZJYLJin Medical InternationalN/A2.502.19Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipGUTSFractyl HealthN/AICADiCAD24.61%NMTCNeuroOne Medical Technologies16.07%ZJYLJin Medical InternationalN/AInsider OwnershipCompanyInsider OwnershipGUTSFractyl HealthN/AICADiCAD10.29%NMTCNeuroOne Medical Technologies8.90%ZJYLJin Medical InternationalN/ACompare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableGUTSFractyl Health10248.98 millionN/AN/AICADiCAD14027.47 million23.81 millionOptionableNMTCNeuroOne Medical Technologies2049.82 million28.12 millionOptionableZJYLJin Medical International245156.55 millionN/ANot OptionableNMTC, GUTS, ICAD, and ZJYL HeadlinesRecent News About These CompaniesJin Medical International Ltd. (NASDAQ:ZJYL) Sees Significant Growth in Short InterestJune 1, 2025 | marketbeat.comJin Medical International (NASDAQ:ZJYL) Trading Up 0.8% - Here's What HappenedMay 29, 2025 | marketbeat.comJin Medical Faces Nasdaq Listing Compliance ChallengeMay 6, 2025 | tipranks.comJin Medical International Ltd. -- Nasdaq Minimum Bid Price Non-ComplianceMay 6, 2025 | gurufocus.comJin Medical International Ltd. – Nasdaq Minimum Bid Price Non-ComplianceMay 6, 2025 | globenewswire.comIs Jin Medical International Ltd.'s (NASDAQ:ZJYL) Recent Stock Performance Influenced By Its Fundamentals In Any Way?April 28, 2025 | finance.yahoo.comJin Medical Boosts Production Capacity with New Chuzhou FacilityApril 25, 2025 | tipranks.comJIN MEDICAL INTERNATIONAL LTD. Ordinary Shares (ZJYL)April 13, 2025 | nasdaq.comWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Down 12.45%April 3, 2025 | aaii.comWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Up 10.09%March 25, 2025 | aaii.comWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Down 29.03%March 22, 2025 | aaii.comWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Up 14.61%March 20, 2025 | aaii.comWhy Jin Medical International Ltd.’s (ZJYL) Stock Is Up 11.29%January 31, 2025 | aaii.comJin Medical International Full Year 2024 Earnings: EPS: US$0.023 (vs US$0.02 in FY 2023)January 27, 2025 | finance.yahoo.comWuhan Jin Jiang International HotelNovember 12, 2024 | travelweekly.comJin of BTS fronts rock band in 'I'll Be There' music videoOctober 25, 2024 | msn.comConstruction of JinMed's New Facility Begins in Chuzhou, ChinaOctober 10, 2024 | globenewswire.comSome Investors May Be Worried About Jin Medical International's (NASDAQ:ZJYL) Returns On CapitalOctober 9, 2024 | finance.yahoo.comZJYL Sees a Stock Surge of 5.04% Amid Positive Financial PerformanceOctober 2, 2024 | gurufocus.comCrude Oil Down Over 1%; US Manufacturing PMI Falls In SeptemberSeptember 24, 2024 | msn.comUnited States shares mixed at close of trade; Dow Jones Industrial Average up 0.09%September 21, 2024 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNMTC, GUTS, ICAD, and ZJYL Company DescriptionsFractyl Health NASDAQ:GUTS$2.06 -0.11 (-5.07%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$2.11 +0.05 (+2.43%) As of 06/13/2025 07:54 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Fractyl Health, Inc., a metabolic therapeutics company, develops therapies for the treatment of type 2 diabetes (T2D) and obesity. The company develops Revita DMR System (Revita), an outpatient procedural therapy designed to durably modify duodenal dysfunction, a pathologic consequence of a high fat and high sugar diet, which can initiate T2D and obesity in humans. It also develops Rejuva, a novel adeno-associated virus delivered pancreatic gene therapy platform that is designed to enable long-term remission of T2D and obesity by durably altering metabolic hormone function in the pancreatic islet cells of patients. Fractyl Health, Inc. was formerly known as Fractyl Laboratories Inc. and changed its name to Fractyl Health, Inc. on June 09, 2021. The company was incorporated in 2010 and is headquartered in Burlington, Massachusetts.iCAD NASDAQ:ICAD$3.68 -0.08 (-2.13%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$3.70 +0.02 (+0.54%) As of 06/13/2025 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.iCAD, Inc. engages in the provision of cancer detection and therapy solutions in the United States. It operates through two segments, Detection and Therapy. The company provides ProFound AI for digital breast tomosynthesis and 2D mammography; PowerLook, a density assessment solution; and ProFound Risk, a breast cancer risk analysis. The company was formerly known as Howtek, Inc. and changed its name to iCAD, Inc. in June 2002. iCAD, Inc. was incorporated in 1984 and is headquartered in Nashua, New Hampshire.NeuroOne Medical Technologies NASDAQ:NMTC$0.56 -0.01 (-2.09%) Closing price 06/13/2025 04:00 PM EasternExtended Trading$0.59 +0.02 (+4.27%) As of 06/13/2025 06:00 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.Jin Medical International NASDAQ:ZJYL$0.68 -0.01 (-1.80%) Closing price 06/13/2025 03:59 PM EasternExtended Trading$0.70 +0.01 (+1.82%) As of 06/13/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Jin Medical International Ltd. engages in the design, development, manufacturing, and sale of wheelchair and other living aids products for people with disabilities or impaired mobility in China and internationally. It also offers oxygen concentrators and bathing machines. The company was founded in 2006 and is based in Changzhou, China. Jin Medical International Ltd. is a subsidiary of Jolly Harmony Enterprises Limited. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/09 - 06/13 Alphabet Enters a Bull Market: Is It Time to Buy? Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones RH Stock Rockets on Surprise Profit and Tariff Shift Super Micro Computer Stock: 2 Levels Smart Money Is Watching Intel's Price Spikes: Noise, or the First Notes of a Turnaround? IBM Up 10 Days in a Row: What’s Driving the Winning Streak? SoFi Stock’s Next Test: Can It Justify Its Premium Valuation? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
